Shu D - Search Results

1

Controllable Self-Assembly of RNA Tetrahedrons with Precise Shape and Size for Cancer Targeting.

Li H, Zhang K, Pi F, Guo S, Shlyakhtenko L, Chiu W, Shu D, Guo P. Li H, et al. Among authors: shu d. Adv Mater. 2016 Sep;28(34):7501-7. doi: 10.1002/adma.201601976. Epub 2016 Jun 20. Adv Mater. 2016. PMID: 27322097 Free PMC article.

2

Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.

Shu Y, Haque F, Shu D, Li W, Zhu Z, Kotb M, Lyubchenko Y, Guo P. Shu Y, et al. Among authors: shu d. RNA. 2013 Jun;19(6):767-77. doi: 10.1261/rna.037002.112. Epub 2013 Apr 19. RNA. 2013. PMID: 23604636 Free PMC article.

3

Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Shu Y, Pi F, Sharma A, Rajabi M, Haque F, Shu D, Leggas M, Evers BM, Guo P. Shu Y, et al. Among authors: shu d. Adv Drug Deliv Rev. 2014 Feb;66:74-89. doi: 10.1016/j.addr.2013.11.006. Epub 2013 Nov 22. Adv Drug Deliv Rev. 2014. PMID: 24270010 Free PMC article. Review.

4

Using RNA nanoparticles with thermostable motifs and fluorogenic modules for real-time detection of RNA folding and turnover in prokaryotic and eukaryotic cells.

Zhang H, Pi F, Shu D, Vieweger M, Guo P. Zhang H, et al. Among authors: shu d. Methods Mol Biol. 2015;1297:95-111. doi: 10.1007/978-1-4939-2562-9_7. Methods Mol Biol. 2015. PMID: 25895998

5

RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.

Li H, Rychahou PG, Cui Z, Pi F, Evers BM, Shu D, Guo P, Luo W. Li H, et al. Among authors: shu d. Nucleic Acid Ther. 2015 Aug;25(4):188-97. doi: 10.1089/nat.2014.0525. Epub 2015 May 27. Nucleic Acid Ther. 2015. PMID: 26017686 Free PMC article.

6

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.

Shu D, Li H, Shu Y, Xiong G, Carson WE 3rd, Haque F, Xu R, Guo P. Shu D, et al. Among authors: shu y. ACS Nano. 2015 Oct 27;9(10):9731-40. doi: 10.1021/acsnano.5b02471. Epub 2015 Sep 21. ACS Nano. 2015. PMID: 26387848 Free PMC article.

7

Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.

Binzel DW, Shu Y, Li H, Sun M, Zhang Q, Shu D, Guo B, Guo P. Binzel DW, et al. Among authors: shu d, shu y. Mol Ther. 2016 Aug;24(7):1267-77. doi: 10.1038/mt.2016.85. Epub 2016 Apr 29. Mol Ther. 2016. PMID: 27125502 Free PMC article.

8

Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles.

Zhang Y, Leonard M, Shu Y, Yang Y, Shu D, Guo P, Zhang X. Zhang Y, et al. Among authors: shu d, shu y. ACS Nano. 2017 Jan 24;11(1):335-346. doi: 10.1021/acsnano.6b05910. Epub 2016 Dec 16. ACS Nano. 2017. PMID: 27966906 Free PMC article.

9

RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.

Lee TJ, Yoo JY, Shu D, Li H, Zhang J, Yu JG, Jaime-Ramirez AC, Acunzo M, Romano G, Cui R, Sun HL, Luo Z, Old M, Kaur B, Guo P, Croce CM. Lee TJ, et al. Among authors: shu d. Mol Ther. 2017 Jul 5;25(7):1544-1555. doi: 10.1016/j.ymthe.2016.11.016. Epub 2017 Jan 18. Mol Ther. 2017. PMID: 28109960 Free PMC article.

10

Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.

Xu C, Haque F, Jasinski DL, Binzel DW, Shu D, Guo P. Xu C, et al. Among authors: shu d. Cancer Lett. 2018 Feb 1;414:57-70. doi: 10.1016/j.canlet.2017.09.043. Epub 2017 Oct 5. Cancer Lett. 2018. PMID: 28987384 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters